Sarah Breevoort, MD
Neurology · Charleston, SCNPI 1619409687
Payments from drug & device makers
What this record shows
This record is dominated by grants: $87,750 of the $89,611 with a category attached, or 97.9%. Biogen accounts for 98.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $87,750 and has fallen 99.4% since, to $489 in 2025. Among neurology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $4716.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$88K
- Catalyst Pharmaceuticals, Inc.$871
- Genentech USA, Inc.$237
- Argenx US, Inc.$174
- Piramal Critical Care$54
- Medtronic$36
- plus $46 from 2 others
What the payments were for
- Grants$87,75098%
- Travel & lodging$5791%
- Food & beverage$1,1451%
- Education$1380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 7 | $88,193 |
| Catalyst Pharmaceuticals, Inc. | 4 | $871 |
| Genentech USA, Inc. | 2 | $237 |
| Argenx US, Inc. | 2 | $174 |
| Piramal Critical Care | 1 | $54 |
| Medtronic | 1 | $36 |
| ITF Therapeutics LLC | 1 | $24 |
| Sarepta Therapeutics, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$89,611 in reported general payments places this provider in the 95th percentile of 270 neurology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Radicava OrsEdaravone | 51 | $659,688 |
| EvrysdiRisdiplam | 16 | $420,384 |
| Riluzole | 95 | $9,400 |
| Baclofen | 20 | $7,412 |
| Duloxetine Hcl | 66 | $2,291 |
| Glycopyrrolate | 14 | $1,657 |
| Mexiletine Hcl | 18 | $1,153 |
| Gabapentin | 70 | $470 |
| Pregabalin | 35 | $310 |
| Nortriptyline Hcl | 15 | $155 |
| Amitriptyline Hcl | 25 | $100 |
| Prednisone | 12 | $44 |
| Meloxicam | 16 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Genentech USA, Inc.Evrysdi | $237 | $420,38416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 270 neurology providers in South Carolina.
Other neurology in Charleston
- Robert AdamsCharleston$204K
- Tanya TuranCharleston$77K
- Katherine RuzhanskyCharleston$52K
- Jonathan HalfordCharleston$48K
- Andrew KeeganCharleston$48K
- Aljoeson WalkerCharleston$35K
- Hamid BahadoriCharleston$29K
- Bruce OvbiageleCharleston$27K
- Andrew AmeriCharleston$24K
- Robert BolenCharleston$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.